Search
Osteoarthritis Clinical Trials in Columbus, OH
A listing of 6 Osteoarthritis clinical trials in Columbus, OH actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
1 - 6 of 6
The city of Columbus, Ohio, currently has 6 active clinical trials seeking participants for Osteoarthritis research studies.
Featured Therapy
Unique Treatment for High Blood Pressure
Worried about high blood pressure? Think beyond typical high blood pressure treatments.
People who may be candidates for this procedure:
• Are at least 18 years old
• Have been unable to manage their high blood pressure with medications or lifestyle changes alone¹
Learn about a safe and effective procedure that may help reduce high blood pressure. See if you qualify today.
¹ Kandzari DE, et al. J Am Coll Cardiol. Nov 7, 2023;82(19):1809-1823.
People who may be candidates for this procedure:
• Are at least 18 years old
• Have been unable to manage their high blood pressure with medications or lifestyle changes alone¹
Learn about a safe and effective procedure that may help reduce high blood pressure. See if you qualify today.
¹ Kandzari DE, et al. J Am Coll Cardiol. Nov 7, 2023;82(19):1809-1823.
Conditions:
High Blood Pressure
High Blood Pressure (& [Essential Hypertension])
High Blood Pressure (Hypertension).
Hypertension
Essential Hypertension
Featured Trial
Paid Clinical Studies Nationwide
Recruiting
Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.
Conditions:
Healthy
Healthy Volunteer Study
Featured Offer
Discover Affordable Semaglutide Providers
We Checked the Checkout Page on Every Semaglutide Provider. Here's What We Found.
There's a big difference between the price on a landing page and what you actually pay. We went all the way through checkout so you know exactly what to expect.
📋 5 providers ranked by true monthly cost
💵 Options starting as low as $149/month
🏥 Only licensed providers using FDA-registered pharmacies
⭐ Real Trustpilot scores included — including the ones with mixed reviews
🔒 Includes cancellation policy warnings so you don't get stuck
There's a big difference between the price on a landing page and what you actually pay. We went all the way through checkout so you know exactly what to expect.
📋 5 providers ranked by true monthly cost
💵 Options starting as low as $149/month
🏥 Only licensed providers using FDA-registered pharmacies
⭐ Real Trustpilot scores included — including the ones with mixed reviews
🔒 Includes cancellation policy warnings so you don't get stuck
Conditions:
Weight Loss
Morbid Obesity
Featured Trial
Rheumatoid Arthritis (RA) Clinical Research Study
Recruiting
The Ntrust-2 study is a clinical research study evaluating an investigational cell therapy, called NKX019, in adults living with rheumatoid arthritis (RA).
The Ntrust-2 study
The Ntrust-2 study is part of a broad effort of the global research community to develop more treatment options for people living with rheumatoid arthritis.
What is NKX019?
NKX019 is an investigational cell therapy being studied for rheumatoid arthritis (RA). It is designed to target and remove the cells that may trigger harmful antibodies, which attack the body’s own tissues in these conditions.
Who can join this study?
You may be eligible to participate in this study if you:
- Are 18 to 75 years old
- Have been diagnosed with rheumatoid arthritis (RA)
- Have received prior autoimmune disease treatments that may have not worked well for you
Compensation
If you are eligible and choose to participate, you will receive NKX019 and health assessments from a team with expertise in caring for people living with autoimmune disease. Costs for travel, lodging, childcare, and meals will be covered when you and your care partner go to the study clinic. Compensation for study participants and your care partner may also be available.
The Ntrust-2 study
The Ntrust-2 study is part of a broad effort of the global research community to develop more treatment options for people living with rheumatoid arthritis.
What is NKX019?
NKX019 is an investigational cell therapy being studied for rheumatoid arthritis (RA). It is designed to target and remove the cells that may trigger harmful antibodies, which attack the body’s own tissues in these conditions.
Who can join this study?
You may be eligible to participate in this study if you:
- Are 18 to 75 years old
- Have been diagnosed with rheumatoid arthritis (RA)
- Have received prior autoimmune disease treatments that may have not worked well for you
Compensation
If you are eligible and choose to participate, you will receive NKX019 and health assessments from a team with expertise in caring for people living with autoimmune disease. Costs for travel, lodging, childcare, and meals will be covered when you and your care partner go to the study clinic. Compensation for study participants and your care partner may also be available.
Conditions:
Rheumatoid
Rheumatoid Arthritis
Arthritis
Rheumatoid
Rheumatoid Arthritis (RA)
Featured Offer
Discover The Best Tirzepatide Providers
Finding legit tirzepatide online shouldn't feel like a gamble — but with hundreds of providers out there, it often does. We ranked the top 10 so you don't have to.
✅ Providers starting at $242/month
✅ Only accredited, licensed compounding pharmacies
✅ Ranked by real pricing, not marketing promises
✅ Includes patient reviews & hidden fee warnings
✅ Updated for 2026
✅ Providers starting at $242/month
✅ Only accredited, licensed compounding pharmacies
✅ Ranked by real pricing, not marketing promises
✅ Includes patient reviews & hidden fee warnings
✅ Updated for 2026
Conditions:
Overweight
Overweight and Obesity
Featured Trial
Obesity (BMI >= 30) Clinical Study
Recruiting
A clinical study for people that suffer with Obesity (BMI >= 30)
Conditions:
Obesity (BMI >= 30)
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
Recruiting
The purpose of the chronic pain master protocol is to compare independent pain interventions and establish an overarching structure for the disease-state addenda (DSA) and intervention-specific appendices (ISAs). The ISAs may start independently of other ISAs as interventions become available for clinical testing.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/22/2025
Locations: Aventiv Research Inc, Columbus, Ohio
Conditions: Osteoarthritis, Knee, Diabetic Neuropathic Pain, Chronic Low-back Pain
MOTION Clinical Trial
Recruiting
Prospective, multicenter, two-arm, 2:1 randomized controlled trial (RCT) comparing the benefits in subjects with medial knee osteoarthritis who are treated with either the MISHA Knee System or with non-surgical treatment.
This is the first randomized head-to-head study comparing outcomes from subjects treated with the MISHA Knee System.
Gender:
ALL
Ages:
All
Trial Updated:
07/08/2025
Locations: Ohio State Jameson Crane Sports Medicine Institute, Columbus, Ohio
Conditions: Osteoarthritis, Knee
Shoulder iD™ Primary Reversed Glenoid Outcomes Clinical Study
Recruiting
The goal of the Shoulder iD™ Primary Reversed Glenoid Outcomes Clinical Study is to collect safety and performance data on the commercially available Shoulder iD™ Primary Reversed Glenoid device. The study will learn about standard device use in adult patients who have a functional deltoid muscle and massive and non-repairable rotator cuff tear. The main questions it aims to answer are:
* What is the average improvement in patient-reported shoulder function after 2 years when compared to before... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
05/22/2025
Locations: Jameson Crane Sports Medicine Institute OSU, Columbus, Ohio
Conditions: Rotator Cuff Tears, Rheumatoid Arthritis Shoulder, Osteoarthritis Shoulder, Avascular Necrosis of the Head of Humerus, Fracture, Humeral, Traumatic Arthritis of Right Shoulder Region (Diagnosis), Shoulder Deformity
ZILRETTA in Subjects With Shoulder Osteoarthritis
Recruiting
Primary Objective: To assess the efficacy of ZILRETTA on pain following an intra-articular (IA) injection in subjects with glenohumeral osteoarthritis (OA) relative to normal saline placebo
Secondary Objective:
* To assess the efficacy of ZILRETTA on pain following an IA injection in subjects with glenohumeral OA relative to triamcinolone acetonide injectable suspension, immediate release (TCA-IR) and normal saline placebo
* To assess the safety of ZILRETTA in subjects with glenohumeral OA rel... Read More
Gender:
ALL
Ages:
Between 50 years and 80 years
Trial Updated:
05/19/2025
Locations: Ohio State University, Columbus, Ohio
Conditions: Glenohumeral Osteoarthritis
Preventing Injured Knees From osteoArthritis: Severity Outcomes
Recruiting
This study is being done to find out if metformin is effective at reducing pain by delaying the onset of post-traumatic osteoarthritis (PTOA) after anterior cruciate ligament (ACL) reconstruction. This research study will compare metformin to placebo. The placebo tablet looks exactly like metformin, but contains no metformin. Placebos are used in research studies to see if the results are due to the study drug or due to other reasons.
Metformin is approved by the U.S. Food and Drug Administrati... Read More
Gender:
ALL
Ages:
Between 18 years and 45 years
Trial Updated:
04/25/2025
Locations: The Ohio State University, Columbus, Ohio
Conditions: Osteoarthritis, Knee, Post-traumatic Osteoarthritis, ACL Tear
GAE Using Embosphere Microspheres vs Corticosteroid Injections for Treatment of Symptomatic Knee OA (MOTION)
Recruiting
This multicenter, prospective, interventional trial is designed to assess the outcome of subjects with symptomatic knee osteoarthritis (OA) that are randomized to treatment with either genicular artery embolization (GAE) using Embosphere Microspheres or steroid injection over a period of 24 months.
Gender:
ALL
Ages:
21 years and above
Trial Updated:
04/03/2025
Locations: The Ohio State University, Columbus, Ohio
Conditions: Knee Osteoarthritis
1 - 6 of 6
